Breast cancer, and in particular TNBC, presents significant genomic defects [9–12] involving protein degradation [13–15], mutations or deregulation of the p53 family members of tumor suppressors [16–20] as well as of other transcription factors [21–23]. The gene discussed is TP53; the disease is breast carcinoma.